Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Bevacizumab regimen with Carboplatin and Taxol
ID: S900005490


  • NCI: A chemoimmunotherapy regimen consisting of carboplatin, paclitaxel (Taxol) and bevacizumab used for the treatment of advanced-stage, nonsquamous non-small cell lung cancer. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Name of Substance

  • Bevacizumab regimen with Carboplatin and Taxol


  • Carboplatin-paclitaxel-bevacizumab regimen
  • Carboplatin-Taxol-bevacizumab
  • Carboplatin-Taxol-bevacizumab regimen

Registry Number

  • S900005490